Brokerages Set UnitedHealth Group Incorporated (NYSE:UNH) PT at $455.92

UnitedHealth Group Incorporated (NYSE:UNH) has earned a consensus rating of “Moderate Buy” from the twenty-seven ratings firms that are covering the company, MarketBeat Ratings reports. Five analysts have rated the stock with a hold recommendation, twenty have issued a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $455.9231.

Several brokerages have issued reports on UNH. Mizuho boosted their price target on UnitedHealth Group from $470.00 to $493.00 and gave the company an “outperform” rating in a research note on Monday, July 20th. BMO Capital Markets set a $512.00 target price on shares of UnitedHealth Group in a research report on Tuesday, July 21st. HSBC raised their price target on shares of UnitedHealth Group from $300.00 to $380.00 and gave the stock a “hold” rating in a report on Monday, July 6th. HC Wainwright set a $492.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, May 27th. Finally, Leerink Partners upped their price target on UnitedHealth Group from $400.00 to $462.00 and gave the stock an “outperform” rating in a research note on Wednesday, June 17th.

UnitedHealth Group Price Performance

UNH stock opened at $415.21 on Thursday. The company has a quick ratio of 0.80, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. The company’s fifty day simple moving average is $411.93 and its 200 day simple moving average is $348.89. UnitedHealth Group has a 12-month low of $236.95 and a 12-month high of $461.62. The firm has a market cap of $377.07 billion, a price-to-earnings ratio of 26.72, a PEG ratio of 1.44 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, topping the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm had revenue of $112.03 billion during the quarter, compared to analyst estimates of $110.81 billion. During the same period last year, the company posted $4.08 EPS. The business’s quarterly revenue was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, analysts expect that UnitedHealth Group will post 19.69 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th were issued a dividend of $2.32 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.21. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date was Monday, June 15th. UnitedHealth Group’s dividend payout ratio is 59.72%.

Institutional Trading of UnitedHealth Group

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Eagle Bay Advisors LLC purchased a new stake in shares of UnitedHealth Group in the second quarter worth approximately $220,000. Ascent Group LLC raised its position in UnitedHealth Group by 16.4% in the 2nd quarter. Ascent Group LLC now owns 19,555 shares of the healthcare conglomerate’s stock valued at $8,127,000 after buying an additional 2,750 shares during the last quarter. Summit Securities Group LLC grew its stake in shares of UnitedHealth Group by 392.6% in the 2nd quarter. Summit Securities Group LLC now owns 6,300 shares of the healthcare conglomerate’s stock worth $2,618,000 after acquiring an additional 5,021 shares in the last quarter. Commonwealth Retirement Investments LLC grew its position in UnitedHealth Group by 52.2% in the 2nd quarter. Commonwealth Retirement Investments LLC now owns 15,970 shares of the healthcare conglomerate’s stock worth $6,638,000 after purchasing an additional 5,478 shares in the last quarter. Finally, TCW Group Inc. lifted its position in shares of UnitedHealth Group by 47.1% during the 2nd quarter. TCW Group Inc. now owns 201,129 shares of the healthcare conglomerate’s stock worth $83,595,000 after buying an additional 64,368 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.